Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Article in English | MEDLINE | ID: mdl-37796015

ABSTRACT

BACKGROUND: The diagnosis of celiac disease (CD) is still challenging and tests that show an activation of the immune system against gluten are required. IgA antiendomysial antibodies detection in the supernatant of intestinal biopsies by immunofluorescence technique (AEA-biopsy) is a promising diagnostic tool. The aim of the present study was to evaluate the diagnostic accuracy of AEA-biopsy in a pediatric population with suspected CD. METHODS: All children who underwent upper gastrointestinal endoscopy at the Unit of Pediatrics of Treviso Hospital were enrolled and divided into 4 groups: classical CD, CD excluded, potential CD and control group. For each patient, serum autoantibodies and histological evaluation were determined. Two additional biopsy samples were taken to test for presence of AEA. RESULTS: A total of 92 patients were enrolled. All the classical CD cases (38) had a positive AEA-biopsy. In the CD excluded group (10 in total) AEA-biopsy was negative in all patients except 1. Among potential CD patients (which were 14), AEA-biopsy was negative in 4. In the control group (30 patients) AEA-biopsy was negative in all patients except 1. The sensitivity and specificity of AEA-biopsy were 100% and 96% respectively. CONCLUSIONS: AEA-biopsy has an excellent diagnostic accuracy in a routine clinical setting.

2.
Int J Mol Sci ; 24(12)2023 Jun 20.
Article in English | MEDLINE | ID: mdl-37373540

ABSTRACT

Glucosamine (GlcN) is a glycosaminoglycan (GAGs) constituent in connective tissues. It is naturally produced by our body or consumed from diets. In the last decade, in vitro and in vivo trials have demonstrated that the administration of GlcN or its derivates has a protective effect on cartilage when the balance between catabolic and anabolic processes is disrupted and cells are no longer able to fully compensate for the loss of collagen and proteoglycans. To date, these benefits are still controversial because the mechanism of action of GlcN is not yet well clarified. In this study, we have characterized the biological activities of an amino acid (AA) derivate of GlcN, called DCF001, in the growth and chondrogenic induction of circulating multipotent stem cells (CMCs) after priming with tumor necrosis factor-alpha (TNFα), a pleiotropic cytokine commonly expressed in chronic inflammatory joint diseases. In the present work, stem cells were isolated from the human peripheral blood of healthy donors. After priming with TNFα (10 ng/mL) for 3 h, cultures were treated for 24 h with DCF001 (1 µg/mL) dissolved in a proliferative (PM) or chondrogenic (CM) medium. Cell proliferation was analyzed using a Corning® Cell Counter and trypan blue exclusion technique. To evaluate the potentialities of DCF001 in counteracting the inflammatory response to TNFα, we measured the amount of extracellular ATP (eATP) and the expression of adenosine-generating enzymes CD39/CD73, TNFα receptors, and NF-κB inhibitor IκBα using flow cytometry. Finally, total RNA was extracted to perform a gene expression study of some chondrogenic differentiation markers (COL2A1, RUNX2, and MMP13). Our analysis has shed light on the ability of DCF001 to (a) regulate the expression of CD39, CD73, and TNF receptors; (b) modulate eATP under differentiative induction; (c) enhance the inhibitory activity of IκBα, reducing its phosphorylation after TNFα stimulation; and (d) preserve the chondrogenic potentialities of stem cells. Although preliminary, these results suggest that DCF001 could be a valuable supplement for ameliorating the outcome of cartilage repair interventions, enhancing the efficacy of endogenous stem cells under inflammatory stimuli.


Subject(s)
Chondrocytes , Glucosamine , Humans , Glucosamine/pharmacology , Glucosamine/metabolism , NF-KappaB Inhibitor alpha/metabolism , Chondrocytes/metabolism , Tumor Necrosis Factor-alpha/metabolism , Stem Cells , Cell Differentiation , Inflammation/drug therapy , Inflammation/metabolism , Chondrogenesis , Cells, Cultured
3.
Pharmaceuticals (Basel) ; 14(12)2021 Nov 28.
Article in English | MEDLINE | ID: mdl-34959635

ABSTRACT

AIM: Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic abdominal pain and stool irregularities. STW 5 has proven clinical efficacy in functional gastrointestinal disorders, including IBS, targeting pathways that suppress inflammation and protect the mucosa. Wnt signaling is known to modulate NF-kß-dependent inflammatory cytokine production. This sparked the idea of evaluating the impact of STW 5 on the expression of inflammatory-response and Wnt/ß catenin-target genes in an IBS-like model. MAIN METHODS: We used zebrafish and dextran sodium sulfate (DSS) treatment to model IBS-like conditions in vivo and in vitro and examined the effects of subsequent STW 5 treatment on the intestines of DSS-treated fish and primary cultured intestinal and neuronal cells. Gross gut anatomy, histology, and the expression of Wnt-signaling and cytokine genes were analyzed in treated animals and/or cells, and in controls. KEY FINDINGS: DSS treatment up-regulated the expression of interleukin-8, tumor necrosis factor-α, wnt3a, and claudin-1 in explanted zebrafish gut. Subsequent STW 5 treatment abolished both the macroscopic signs of gut inflammation, DSS-induced mucosecretory phenotype, and normalized the DSS-induced upregulated expression of il10 and Wnt signaling genes, such as wnt3a and cldn1 in explanted zebrafish gut. Under inflammatory conditions, STW 5 downregulated the expression of the pro-inflammatory cytokine genes il1ß, il6, il8, and tnfα while it upregulated the expression of the anti-inflammatory genes il10 and wnt3a in enteric neuronal cells in vitro. SIGNIFICANCE: Wnt signaling could be a novel target for the anti-inflammatory and intestinal permeability-restoring effects of STW 5, possibly explaining its clinical efficacy in IBS.

4.
Updates Surg ; 73(6): 2315-2319, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33877588

ABSTRACT

The laparoscopic splenectomy in pediatric patients is performed worldwide but often the disproportion between size of patients and size of organs requires an extra laparotomic access for spleen removal. The aim of the present study was to evaluate the safety and effectiveness of the Alexis® system to retrieve the spleen without additional laparotomic access. The charts of all patients who underwent splenectomy at our center during the last 5 years were retrieved. In all the cases the Alexis® system was placed in the umbilicus, thru which a 10 mm camera was inserted. Three additional 5 mm standard trocars were inserted. Seven patients, affected by spherocytosis (3), epidermoid cyst (2), idiopathic thrombocytopenic purpura (2) and thalassemia (1), underwent laparoscopic splenectomy at a median age of 10 years (range: 8-17). Median patients' weight was 32.5 kg (range: 25-71) and spleen size 15 cm (11-18). In all the cases, upon removal of the camera, the retrieval bag was inserted thru the umbilicus under direct view, the spleen retrieved, morcellated, and removed. No conversion nor enlargement of one of the ports nor an extra laparotomic access were required. The patients were discharged on the fifth post-operative day and the cosmetic results were excellent. Removal of the spleen can be safely performed without any additional laparotomy thru the Alexis® system placed in the umbilicus. This system is effective also in case of major patient/organ size disproportion and the final cosmetic aspect is excellent.


Subject(s)
Laparoscopy , Purpura, Thrombocytopenic, Idiopathic , Spherocytosis, Hereditary , Adolescent , Child , Humans , Purpura, Thrombocytopenic, Idiopathic/surgery , Spherocytosis, Hereditary/surgery , Spleen/surgery , Splenectomy
5.
Tissue Eng Regen Med ; 18(3): 411-427, 2021 06.
Article in English | MEDLINE | ID: mdl-33625723

ABSTRACT

BACKGROUND: Stem cell therapy is gaining momentum as an effective treatment strategy for degenerative diseases. Adult stem cells isolated from various sources (i.e., cord blood, bone marrow, adipose tissue) are being considered as a realistic option due to their well-documented therapeutic potentials. Our previous studies standardized a method to isolate circulating multipotent cells (CMCs) that are able to sustain long term in vitro culture and differentiate towards mesodermal lineages. METHODS: In this work, long-term cultures of CMCs were stimulated to study in vitro neuronal and myogenic differentiation. After induction, cells were analysed at different time points. Morphological studies were performed by scanning electron microscopy and specific neuronal and myogenic marker expression were evaluated using RT-PCR, flow cytometry and western blot. For myogenic plasticity study, CMCs were transplanted into in vivo model of chemically-induced muscle damage. RESULTS: After neurogenic induction, CMCs showed characteristic dendrite-like morphology and expressed specific neuronal markers both at mRNA and protein level. The calcium flux activity of CMCs under stimulation with potassium chloride and the secretion of noradrenalin confirmed their ability to acquire a functional phenotype. In parallel, the myogenic potential of CMCs was confirmed by their ability to form syncytium-like structures in vitro and express myogenic markers both at early and late phases of differentiation. Interestingly, in a rat model of bupivacaine-induced muscle damage, CMCs integrated within the host tissue taking part in tissue repair. CONCLUSION: Overall, collected data demonstrated long-term cultured CMCs retain proliferative and differentiative potentials suggesting to be a good candidate for cell therapy.


Subject(s)
Adult Stem Cells , Muscle Development , Adipose Tissue , Animals , Cell Differentiation , Neurogenesis , Rats
6.
Eur J Pediatr Surg ; 27(2): 155-160, 2017 Apr.
Article in English | MEDLINE | ID: mdl-26962678

ABSTRACT

Introduction Testicular microlithiasis (TM), characterized by the presence of intratubular calcifications in a single or both the gonads, is an uncommon entity with unknown etiology and outcome in pediatric and adolescent age. In this study, the results of a multicenter long-term survey are presented. Materials and Methods From 11 units of pediatric urology/surgery, patients with TM were identified and yearly, followed up in a 7-year period, adopting a specific database. The recorded items were: age at diagnosis, presenting symptoms/associated abnormalities, ultrasonographic finding, surgery and histology at biopsy, if performed. Results Out of 85 patients, 81 were evaluated yearly (4 patients lost to follow-up). TM was bilateral in 66.6% of the patients. Associate genital abnormalities were present in 90%, more frequently undescended/retractile testis (23.4%) and varicocele (22.2%). TM remained unchanged at 4.7 years follow-up in 77 patients (93.8%) and was reduced in 4 patients after 1 to 5 years of inguinoscrotal surgery. Orchiectomy was performed in three patients (3.7%), one for severe testicular hypoplasia and two for seminoma (2.5%), respectively, concurrent and metachronous to diagnosis of TM. Tumorectomy with parenchymal sparing surgery was performed in a teratoma associated with TM. Conclusion TM is a controversial entity, often associated with several inguinogenital features, which rarely can recover. Testicular malignancy, although present in TM, has not proven definitively associated to microliths. Proper counseling, yearly ultrasound, and self-examination are long-term recommended.


Subject(s)
Calculi/diagnostic imaging , Testicular Diseases/diagnostic imaging , Adolescent , Biopsy , Calculi/complications , Calculi/pathology , Child , Disease Progression , Follow-Up Studies , Humans , Italy , Lithiasis , Male , Neoplasms, Germ Cell and Embryonal/complications , Neoplasms, Germ Cell and Embryonal/diagnostic imaging , Prevalence , Prospective Studies , Testicular Diseases/complications , Testicular Diseases/pathology , Testicular Neoplasms/complications , Testicular Neoplasms/diagnostic imaging , Ultrasonography
7.
Nanomedicine (Lond) ; 11(15): 1929-46, 2016 08.
Article in English | MEDLINE | ID: mdl-27246559

ABSTRACT

AIM: We aimed to set up a self-standing, biomimetic scaffold system able to induce and support per se neuronal differentiation of autologous multipotent cells. MATERIALS & METHODS: We isolated a population of human circulating multipotent cells (hCMCs), and used carbon nanotube/polymer nanocomposite scaffolds to mimic electrical/nanotopographical features of the neural environment, and biomimetic peptides reproducing axon guidance cues from neural proteins. RESULTS: hCMCs showed high degree of stemness and multidifferentiative potential; stimuli from the scaffolds and biomimetic peptides could induce and boost hCMC differentiation toward neuronal lineage despite the absence of exogenously added, specific growth factors. CONCLUSION: This work suggests the scaffold-peptides system combined with autologous hCMCs as a functional biomimetic, self-standing prototype for neural regenerative medicine applications.


Subject(s)
Adult Stem Cells/cytology , Biomimetic Materials/chemistry , Multipotent Stem Cells/cytology , Nanotubes, Carbon/chemistry , Neurons/cytology , Peptides/chemistry , Polyesters/chemistry , Tissue Scaffolds/chemistry , Cell Culture Techniques , Cell Differentiation , Cell Proliferation , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Regenerative Medicine , Tissue Engineering
8.
Pediatr Med Chir ; 38(2): 117, 2016 Jun 27.
Article in English | MEDLINE | ID: mdl-27345602

ABSTRACT

Meckel's diverticulum is a common anomaly of the gastrointestinal tract. The most common complications of Meckel's diverticulum are inflammation, bleeding and obstruction. We present a 12-year-old boy with bowel obstruction due to phytobezoar in a Meckel's diverticulum. We describe diagnostic difficulties and our surgery approach comparing it to the literature.


Subject(s)
Bezoars/diagnosis , Intestinal Obstruction/diagnosis , Meckel Diverticulum/diagnosis , Bezoars/complications , Bezoars/surgery , Child , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery , Male , Meckel Diverticulum/complications , Meckel Diverticulum/surgery
9.
Am J Physiol Gastrointest Liver Physiol ; 310(6): G337-46, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26767983

ABSTRACT

In several gut inflammatory or cancer diseases, cell-cell interactions are compromised, and an increased cytoplasmic expression of ß-catenin is observed. Over the last decade, numerous studies provided compelling experimental evidence that the loss of cadherin-mediated cell adhesion can promote ß-catenin release and signaling without any specific activation of the canonical Wnt pathway. In the present work, we took advantage of the ability of lipofectamine-like reagent to cause a synchronous dissociation of adherent junctions in cells isolated from the rat enteric nervous system (ENS) for obtaining an in vitro model of deregulated ß-catenin signaling. Under these experimental conditions, a green fluorescent protein Wnt reporter plasmid called ΔTop_EGFP3a was successfully tested to screen ß-catenin stabilization at resting and primed conditions with exogenous Wnt3a or lipopolysaccharide (LPS). ΔTop_EGFP3a provided a reliable and strong fluorescent signal that was easily measurable and at the same time highly sensitive to modulations of Wnt signaling following Wnt3a and LPS stimulation. The reporter gene was useful to demonstrate that Wnt3a exerts a protective activity in the ENS from overstimulated Wnt signaling by promoting a downregulation of the total ß-catenin level. Based on this evidence, the use of ΔTop_EGFP3a reporter plasmid could represent a more reliable tool for the investigation of Wnt and cross-talking pathways in ENS inflammation.


Subject(s)
Enteric Nervous System , Gastroenteritis/genetics , Genes, Reporter/genetics , Plasmids/genetics , Wnt Signaling Pathway/genetics , Animals , Cell Adhesion/drug effects , Cell Membrane/pathology , Down-Regulation/drug effects , Fluorescence , Gastroenteritis/physiopathology , Green Fluorescent Proteins , Indicators and Reagents , Lipids , Lipopolysaccharides/pharmacology , Rats , Rats, Sprague-Dawley , Wnt3A Protein/pharmacology , beta Catenin/metabolism
10.
Pediatr Med Chir ; 27(1-2): 75-80, 2005.
Article in Italian | MEDLINE | ID: mdl-16922048

ABSTRACT

OBJECTIVE: To evaluate results of Nissen fundoplication in a neurologically impaired children population versus normal, considering symptoms improvement, general conditions, parents satisfaction, facility to assist the patient. METHODS: 57 patients were analysed, 38 neurologically impaired children (NL),19 neurologically normal children (NNL), that underwent fundoplication during six-year period (Feb '95-Dec '00). Mean age at surgery was 6,8 years (range 3 month- 18 years) for NL; 4,7 years for NNL (1 month- 15 years). We contact 31 family (19 NL, 12 NNL) before and after surgery and we subject them a questionnaire. For data analysis chi-squared test and Mann-Witney Rank Sum test has been used. RESULTS: A significantly greater reduction of the vomit and regurgitation have been observed in both groups (p<0.5). Drooling was significantly reduced only in the NNL group (p<0.5) than in the NL group. Cough doesn't improved significantly in both groups (p>0.5). Major respiratory symptoms and respiratory infections improved significantly only in NL group (p<0.5). The parents satisfaction is high and patients management results easier. CONCLUSIONS: The Nissen fundoplication in NL children is an effective procedure in order to obtain improvement on vomit; major respiratory symptoms and quality of caregivers management.


Subject(s)
Fundoplication , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/surgery , Nervous System Diseases/complications , Adolescent , Child , Child, Preschool , Humans , Infant
SELECTION OF CITATIONS
SEARCH DETAIL
...